NVP-BEZ235 Inhibits Renal Cell Carcinoma by Targeting TAK1 and PI3K/Akt/mTOR Pathways

Overview of attention for article published in Frontiers in Pharmacology, January 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 1 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 5,875 followers.

New Research: NVP-BEZ235 Inhibits Renal Cell Carcinoma by Targeting TAK1 and PI3K/Akt/mTOR Pathways https://t.co/ubX5yvDNwk #pharmacology

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.